CALGARY, ALBERTA--(Marketwired - April 23, 2013) -
NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
PACEpartners Inc. (PACEpartners) (TSX VENTURE:PIA.P) wishes to announce that on April 19, 2013, the date it completed its "Qualifying Transaction" under the capital pool company program of the TSX Venture Exchange, it granted an aggregate of 2,884,377 options to certain directors, officers, consultants and employees of PACEpartners and its operating subsidiary, Vivione Biosciences, LLC at an exercise price of $0.25 per share, exercisable for a maximum period of 10 years from the date of the grant.
The securities mentioned herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release does not constitute an offer to sell or the solicitation of any offer to buy these securities in any jurisdiction.
NEITHER TSX VENTURE EXCHANGE INC. NOR ITS REGULATION SERVICE PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Contact Information:
Kevin Kuykendall
Chief Executive Officer
(214) 886-5733